A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas
for CLL / SLL
4 locations incl. Louisville
Sponsor: Lomond Therapeutics Holdings, Inc.
Sex: All·Age: 18+
Code: NCT06708897·Phase 1·Recruiting